Epion Therapeutics

📍 Burlington, United States👥 12 employees💰 Last funded Oct 2022
Pharmaceutical Manufacturing🌐 epiontx.com
Website LinkedIn
Epion Therapeutics is developing innovative treatments for corneal diseases with the goal of saving and improving vision for millions of patients around the world. EpiSmart, our transformative cross-linking system targeting keratoconus, a common type of corneal ectasia, is designed to be minimally invasive with reduced discomfort and a significantly reduced recovery time versus current standards of care. Epions elegant approach will elevate the standard of care by enabling the treatment of both eyes simultaneously and eliminating the need for further deterioration. With a true epi-on approach that does not disrupt the epithelium, Epion is striving to deliver safer and more accessible vision-preserving care to millions of patients globally.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Epion Therapeutics?
Epion Therapeutics has 1 investors on record on gritt.io.
When did Epion Therapeutics last raise funding?
The most recent investment in Epion Therapeutics recorded on gritt.io was in October 2022.
What industry is Epion Therapeutics in?
Epion Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Epion Therapeutics based?
Epion Therapeutics is headquartered in Burlington, United States.